colab
  • home
  • what we do
  • impact
  • reports
  • collaborate
    • colab releases
  • COVID 19
  • blog
Select Page

Project Orbis. Accelerating time to patient access?

Mar 7, 2023 | access, health policy, oncology, oncopolicy | 0 comments

Timely access to innovative treatments is crucial for those living with cancer. However, for Candians with cancer, the approval process for such treatments can be lengthy and complex. Cancer treatments usually receive Health Canada and subsequent health technology...

Canadians with cancer are asking “where is cancer?” in the proposed healthcare plan announced yesterday

Feb 8, 2023 | health policy, oncology, oncopolicy | 0 comments

PROVIDED BY Cancer Action Now  TORONTO, Feb. 8, 2023 /CNW/ – As the Prime Minister and Premiers convened in Ottawa yesterday to discuss much-needed reforms to Canada’s health systems, cancer patients and stakeholder groups...

the patented medicines review board has lost its way (again)

Nov 8, 2022 | health policy, oncopolicy | 0 comments

this article was originally published on the macdonald laurier laurier institute blog by W. Neil Palmer on November 1.2022 and republished here. The Patented Medicine Prices Review Board (PMPRB) is once again attracting the ire of the life sciences industry and...

open letter: let’s put cancer at the top of the agenda

Nov 7, 2022 | access, health policy, oncology, oncopolicy | 0 comments

as the ministers of health across the country meet in vancouver over the next couple of days, the CANCER ACTION NOW ALLIANCE members have drafted a letter to remind them of the canadians, who every day are diagnosed, treated, screened and die from cancer. an ongoing...

precision medicine awareness month launches in canada

Nov 2, 2020 | oncopolicy, precision medicine | 0 comments

throughout the month of november, the cancer collaborative in collaboration with the european cancer patients coalition [ECPC] will highlight the growing role that precision medicine plays in oncology through the CRACKING THE CANCER CODE campaign.   the premise of...

canadian institute for health information [CIHI] publishes drug spending statistics

Jan 13, 2020 | biosimilars, health policy, oncology, oncopolicy | 0 comments

last december, the canadian institute for health information published statistics on drug spending, finding that in 2018 approximately 40% of drug spending was spent on 2% of beneficiaries. of this 2%, three out of five individuals used a drug therapy that cost...
  • understanding cancer
  • what is precision medicine
  • what is precision medicine awareness month
  • personalized versus precision medicine
  • genetics vs genomics
  • what are biomarkers
  • molecular profiling
  • Twitter
  • Instagram
  • Linkedin